Zur Kurzanzeige

dc.creatorKaltsatou, A.en
dc.creatorSakkas, G. K.en
dc.creatorPoulianiti, K. P.en
dc.creatorKoutedakis, Y.en
dc.creatorTepetes, K.en
dc.creatorChristodoulidis, G.en
dc.creatorStefanidis, I.en
dc.creatorKaratzaferi, C.en
dc.date.accessioned2015-11-23T10:31:13Z
dc.date.available2015-11-23T10:31:13Z
dc.date.issued2015
dc.identifier10.3389/fphys.2015.00102
dc.identifier.issn1664-042X
dc.identifier.urihttp://hdl.handle.net/11615/28805
dc.description.abstractRenal failure is accompanied by progressive muscle weakness and premature fatigue, in part linked to hypokinesis and in part to uremic toxicity. These changes are associated with various detrimental biochemical and morphological alterations. All of these pathological parameters are collectively termed uremic myopathy. Various interventions while helpful can't fully remedy the pathological phenotype. Complex mechanisms that stimulate muscle dysfunction in uremia have been proposed, and oxidative stress could be implicated. Skeletal muscles continuously produce reactive oxygen species (ROS) and reactive nitrogen species (RNS) at rest and more so during contraction. The aim of this mini review is to provide an update on recent advances in our understanding of how ROS and RNS generation might contribute to muscle dysfunction in uremia. Thus, a systematic review was conducted searching PubMed and Scopus by using the Cochrane and PRISMA guidelines. While few studies met our criteria their findings are discussed making reference to other available literature data. Oxidative stress can direct muscle cells into a catabolic state and chronic exposure to it leads to wasting. Moreover, redox disturbances can significantly affect force production per se. We conclude that oxidative stress can be in part responsible for some aspects of uremic myopathy. Further research is needed to discern clear mechanisms and to help efforts to counteract muscle weakness and exercise intolerance in uremic patients.en
dc.sourceFrontiers in Physiologyen
dc.source.uri<Go to ISI>://WOS:000352986400001
dc.subjectoxidative stressen
dc.subjecturemiaen
dc.subjectmuscle dysfunctionen
dc.subjecturemic myopathyen
dc.subjectprematureen
dc.subjectfatigueen
dc.subjectmuscle weaknessen
dc.subjectPATIENTS RECEIVING HEMODIALYSISen
dc.subjectSTAGE RENAL-FAILUREen
dc.subjectSKELETAL-MUSCLEen
dc.subjectDIALYSIS PATIENTSen
dc.subjectREACTIVE OXYGENen
dc.subjectFUNCTIONAL-CAPACITYen
dc.subjectEXERCISEen
dc.subjectATROPHYen
dc.subjectDISEASEen
dc.subjectINFLAMMATIONen
dc.subjectPhysiologyen
dc.titleUremic myopathy: is oxidative stress implicated in muscle dysfunction in uremia?en
dc.typejournalArticleen


Dateien zu dieser Ressource

DateienGrößeFormatAnzeige

Zu diesem Dokument gibt es keine Dateien.

Das Dokument erscheint in:

Zur Kurzanzeige